We analyzed the sensibility, specificity, positive and negative predictive values of the SELDI-TOF-MS trastuzumab resistance standard.
分析该蛋白界定标准评判曲妥珠单抗耐药的灵敏度、特异度以及阳性预测值、阴性预测值。
Conclusions: SELDI-TOF-MS shows great potentiality for breast cancer in early diagnosis and screening of tumor biomarkers, and deserves generalization.
结论：SELDI - TOF - MS技术对乳腺癌早期诊断和特异性肿瘤标记物的筛选等方面具有一定价值，值得推广。
SELDI-TOF-MS proteinchip technology can screen out relatively specific, potential markers from serum of lung adenocarcinoma patients, so it has better clinical value.
SELDI蛋白质芯片技术能直接筛选出肺腺癌患者血清中相对特异的潜在标志物，具有较好的临床应用价值。
SELDI proteinchip technique, which combines the chromatography principle and SELDI, TOF, MS technique, is the newest biochip, and one of the important tools in the research of the tumors proteomics.
SEL DI 蛋白质芯片技术是结合色谱学层析原理和SELDI T OFMS技术制成的新一代生物芯片，是目前肿瘤蛋白质组学研究的重要工具之一。
SELDI proteinchip technique, which combines the chromatography principle and SELDI, TOF, MS technique, is the newest biochip, and one of the important tools in the research of the tumors proteomics.
SEL DI 蛋白质芯片技术是结合色谱学层析原理和SELDI T OFMS技术制成的新一代生物芯片，是目前肿瘤蛋白质组学研究的重要工具之一。
应用推荐